News | Contrast Media | October 10, 2017

Guerbet to Participate in French Interventional Radiology Conference

Company will organize pair of symposiums and present mixing and injection system for conventional trans-arterial chemoembolization

Guerbet to Participate in French Interventional Radiology Conference

October 10, 2017 — Guerbet announced it will be taking part in the 65th edition of the Journées Francophones de Radiologie (JFR) that will be held in Paris, France, Oct. 13-16, 2017.

The JFR, a major international gathering for medical imaging players, annually brings together more than 17,000 diagnostic and interventional radiology experts from France and abroad. This year, the JFR, a place for discussion and debate focusing on innovation, research and development, will place emphasis on the theme "Patients and their Radiologists."

Guerbet will present its integrated magnetic resonance imaging (MRI) and scanner offers as well as its digital solutions. For the sixth consecutive year, Guerbet will also be an exhibitor and partner of the "Interventional Radiology Village" where, for the first time, it will present Vectorio, its conventional trans-arterial chemo-embolization (cTACE) mixing and injection device that obtained the CE mark in September 2017. Vectorio encompasses a set of medical devices that are resistant to Lipiodol Ultra Fluide, used for cTACE

Guerbet will also organize two symposiums during the JFR:

  • "Gadolinium deposits in the brain: what is the current situation?" Friday, Oct. 13 — Prof. Fabrice Bonneville (Toulouse University Hospital) will be the moderator and findings will be presented by Prof. Douraied Ben Salem (Brest University Hospital), Dr. Nicolas Menjot De Champfleur (Montpellier University Hospital), Prof. François Cotton (Lyon Public Hospital) and Prof. Isabelle Thomassin (Tenon Public Hospital, Paris).
  • "Guerbet, the present and future in interventional radiology" Saturday, Oct. 14 — Prof. Afshin Gangi (Strasbourg University Hospital) will be the moderator and Prof. Jean-Pierre Pelage (Caen University Hospital), Prof. Patrick Chevallier (Nice University Hospital) and Prof. Romaric Loffroy (Dijon University hospital) will all present their work.

For more information: www.guerbet.com

Related Content

Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
Machine Learning IDs Markers to Help Predict Alzheimer's

Neurologists use structural and diffusion magnetic resonance imaging (MRI) to identify changes in brain tissue (both gray and white matter) that are characteristic of Alzheimer's disease and other forms of dementia. The MRI images are analyzed using morphometry and tractography techniques, which detect changes in the shape and dimensions of the brain and in the tissue microstructure, respectively. In this example, the images show the normal brain of an elderly patient. Image courtesy of Jiook Cha.

News | Neuro Imaging | September 20, 2018
New research has shown a combination of two different modes of magnetic resonance imaging (MRI), computer-based...
Ingenia Ambition X 1.5T MR. This innovation is the latest advance in the Ingenia MRI portfolio, which comprises fully-digital MRI systems, healthcare informatics and a range of maintenance and life cycle services for integrated solutions that empower a faster, smarter, and simpler path to enabling a confident diagnosis
News | Magnetic Resonance Imaging (MRI) | September 14, 2018
Philips, a global leader in health technology, launched the Ingenia Ambition X 1.5T MR.
Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns, as seen in this MRI.

Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns, as seen in this MRI.

News | Contrast Media | September 12, 2018
In February 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Maryland, to explore co
Veye Chest version 2
News | Lung Cancer | September 11, 2018
Aidence, an Amsterdam-based medical AI company, announced that Veye Chest version 2, a class IIa medical device, has
Sponsored Content | Case Study | Magnetic Resonance Imaging (MRI) | September 07, 2018 | By Sabine Sartoretti, M.D.
As soon as the Compressed SENSE technology became available to the MRI team at Kantonsspital Winterthur (Switzerland),...

Image courtesy of Philips Healthcare

Feature | Magnetic Resonance Imaging (MRI) | September 06, 2018 | By Melinda Taschetta-Millane
According to the Prescient & Strategic Intelligence report, “Global Magnetic Resonance Imaging (MRI) Market Size,...
Brain Iron Levels May Predict Multiple Sclerosis Disabilities
News | Neuro Imaging | August 31, 2018
A new, highly accurate magnetic resonance imaging (MRI) technique can monitor iron levels in the brains of multiple...
Study Finds Multiple Sclerosis Drug Slows Brain Shrinkage

An NIH-funded clinical trial suggested that the anti-inflammatory drug ibudilast may slow brain shrinkage caused by progressive MS. Image courtesy of Robert J. Fox, M.D., Cleveland Clinic.

News | Neuro Imaging | August 30, 2018
August 30, 2018 — Results from a clinical...
Rapid Cardiac MRI Technique May Cut Costs, Boost Care in Developing World
News | Magnetic Resonance Imaging (MRI) | August 29, 2018
A newly developed rapid imaging protocol quickly and cheaply diagnosed heart ailments in patients in Peru, according to...